Iva Hrnčiříková
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iva Hrnčiříková has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jana Halamkova
Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
2 shared publications - Alena Slezackova
Masaryk University
1 shared publication - Dana Vigašová1 shared publication
- Igor Kiss
Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
1 shared publication - Iva Burešová
Faculty of Arts, Masaryk University, Brno, Czech Republic
1 shared publication - Jiří Šedo1 shared publication
Latest Publications
- Open Access
- 2 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Effectiveness and Real-World Use of Self-Guided Mobile Psychological Interventions for Patients With Cancer: Pragmatic Randomized Controlled Trial (Preprint)
BACKGROUND Digital psychological interventions may extend psychosocial support in oncology, but their effectiveness, uptake, and sustained use under routine-care conditions remain uncertain. OBJECTIVE This study evaluated the effectiveness and comparative effectiveness of three self-guided mobile psychological interventions for patients with cancer and examined uptake, adherence, acceptability, and retention. METHODS This pragmatic, single-center, four-arm randomized controlled trial was conducted at the Masaryk Memorial Cancer Institute in Brno, Czech Republic. Adults with cancer were randomized to one of three 8-week interventions—mindfulness-based cognitive therapy for cancer (MBCT-Ca), positive psychology (PP), autogenic training (AT)—or a waitlist control (WL). Outcomes were assessed at baseline (T0), postintervention (T1; primary endpoint), and 3 (T2) and 9 months (T3) postintervention. Seven primary outcomes covered psychological distress, positive mental health, quality of life, and spiritual well-being. Repeated-measures mixed models compared pooled active interventions with waitlist and the three active interventions. Application-use data and postintervention questionnaires assessed uptake, adherence, and acceptability. RESULTS Of 454 eligible participants, 227 (50.0%) completed T0, 88 (38.8% of T0 completers) completed T1, and 31 (13.7%) completed all four assessments. The primary multivariate analysis did not show a significant overall intervention effect (time × intervention: semi-standardized β=0.18, 95% CI −0.05 to 0.41; P=.13). Outcome-specific analyses showed greater reductions in perceived stress (β=−0.40, 95% CI −0.78 to −0.03; P=.03) and greater increases in positive mental health (β=0.46, 95% CI 0.14-0.79; P=.006) in pooled intervention groups versus waitlist; other primary outcomes were not significant. There was no overall difference among active interventions (P=.40), and prespecified superiority hypotheses were not supported. Positive mental health remained significant in complete-case sensitivity analysis (β=0.54, 95% CI 0.16-0.93; P=.006), whereas perceived stress did not. Among T0 completers, 37/227 (16.3%) never logged into the app. Among 140 active-arm participants who logged in, mean program completion was 32.6%, and 98 (70.0%) completed less than half of assigned activities. Among 63 intervention participants completing T1, 61 (96.8%) would recommend the program. Noninitiators were older and had more favorable baseline psychological profiles; later retention was also greater among older participants with more favorable baseline profiles. No significant intervention effects were detected at follow-up. CONCLUSIONS The trial did not demonstrate an overall intervention effect across primary outcomes, although positive mental health showed the most consistent intervention-related signal. Substantial attrition limits effectiveness inferences. Among retained participants, acceptability was high, but uptake and sustained engagement were limited. These findings highlight the importance of considering intervention use and retention alongside clinical outcomes when evaluating self-guided mHealth interventions in routine oncology care. CLINICALTRIAL NCT05221970; https://clinicaltrials.gov/study/NCT05221970
- 2 October 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEffectiveness and Real-World Use of Self-Guided Mobile Psychological Interventions for Patients With Cancer: Pragmatic Randomized Controlled Trial (Preprint)
BACKGROUND Digital psychological interventions may extend psychosocial support in oncology, but their effectiveness, uptake, and sustained use under routine-care conditions remain uncertain. OBJECTIVE This study evaluated the effectiveness and comparative effectiveness of three self-guided mobile psychological interventions for patients with cancer and examined uptake, adherence, acceptability, and retention. METHODS This pragmatic, single-center, four-arm randomized controlled trial was conducted at the Masaryk Memorial Cancer Institute in Brno, Czech Republic. Adults with cancer were randomized to one of three 8-week interventions—mindfulness-based cognitive therapy for cancer (MBCT-Ca), positive psychology (PP), autogenic training (AT)—or a waitlist control (WL). Outcomes were assessed at baseline (T0), postintervention (T1; primary endpoint), and 3 (T2) and 9 months (T3) postintervention. Seven primary outcomes covered psychological distress, positive mental health, quality of life, and spiritual well-being. Repeated-measures mixed models compared pooled active interventions with waitlist and the three active interventions. Application-use data and postintervention questionnaires assessed uptake, adherence, and acceptability. RESULTS Of 454 eligible participants, 227 (50.0%) completed T0, 88 (38.8% of T0 completers) completed T1, and 31 (13.7%) completed all four assessments. The primary multivariate analysis did not show a significant overall intervention effect (time × intervention: semi-standardized β=0.18, 95% CI −0.05 to 0.41; P=.13). Outcome-specific analyses showed greater reductions in perceived stress (β=−0.40, 95% CI −0.78 to −0.03; P=.03) and greater increases in positive mental health (β=0.46, 95% CI 0.14-0.79; P=.006) in pooled intervention groups versus waitlist; other primary outcomes were not significant. There was no overall difference among active interventions (P=.40), and prespecified superiority hypotheses were not supported. Positive mental health remained significant in complete-case sensitivity analysis (β=0.54, 95% CI 0.16-0.93; P=.006), whereas perceived stress did not. Among T0 completers, 37/227 (16.3%) never logged into the app. Among 140 active-arm participants who logged in, mean program completion was 32.6%, and 98 (70.0%) completed less than half of assigned activities. Among 63 intervention participants completing T1, 61 (96.8%) would recommend the program. Noninitiators were older and had more favorable baseline psychological profiles; later retention was also greater among older participants with more favorable baseline profiles. No significant intervention effects were detected at follow-up. CONCLUSIONS The trial did not demonstrate an overall intervention effect across primary outcomes, although positive mental health showed the most consistent intervention-related signal. Substantial attrition limits effectiveness inferences. Among retained participants, acceptability was high, but uptake and sustained engagement were limited. These findings highlight the importance of considering intervention use and retention alongside clinical outcomes when evaluating self-guided mHealth interventions in routine oncology care. CLINICALTRIAL NCT05221970; https://clinicaltrials.gov/study/NCT05221970
- Open Access
- 23 June 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Psychophysiological changes during breast cancer treatment: a longitudinal analysis of subjective and objective indicators
Advances in early detection and treatment of breast cancer have led to improved survival rates, shifting attention toward the physical and psychological consequences of treatment. Adjuvant therapies are frequently associated with fatigue, reduced quality of life, sleep disturbances, and psychological distress, yet longitudinal data capturing changes in both subjective and objective health indicators during treatment remain limited. The present study aimed to examine changes in selected psychophysiological characteristics in breast cancer patients from diagnosis through completion of adjuvant treatment. A longitudinal design with two assessment points was employed: before treatment initiation and after completion of adjuvant therapy. The sample consisted of 75 women with breast cancer (mean age = 52.04; sd = 11.63). Self-report measures assessed fatigue (MFI), quality of life (EORTC QLQ-C30), anxiety and depression (HADS), sleep quality (PSQI), and motivation for physical activity (MPAM-R). Objective indicators included body mass index (BMI) and functional exercise capacity measured by the six-minute walk test (6MWT). Changes over time were analyzed using General Linear Models for repeated measures, with age and treatment duration included as covariates. Holm-Bonferroni correction was applied to control for multiple testing. Following treatment, patients exhibited significant increases in physical and general fatigue and a marked deterioration in the physical component of quality of life. BMI increased modestly but significantly over time. In contrast, no significant change was observed in objectively measured physical fitness (6MWT). Depressive symptoms significantly decreased after treatment, suggesting psychological adaptation despite physical deterioration. Age-related effects indicated greater post-treatment worsening of sleep quality in younger women, whereas older women showed a more pronounced decline in physical quality of life. The findings reveal a notable discrepancy between subjective health perceptions and objective physical capacity during breast cancer treatment. They underscore the importance of routine monitoring of fatigue, quality of life, and body weight, and support the implementation of individualized, age-sensitive supportive care strategies. Addressing psychophysiological burden during treatment may improve long-term well-being and clinical outcomes in breast cancer survivors.
- 23 June 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Open AccessPsychophysiological changes during breast cancer treatment: a longitudinal analysis of subjective and objective indicators
Advances in early detection and treatment of breast cancer have led to improved survival rates, shifting attention toward the physical and psychological consequences of treatment. Adjuvant therapies are frequently associated with fatigue, reduced quality of life, sleep disturbances, and psychological distress, yet longitudinal data capturing changes in both subjective and objective health indicators during treatment remain limited. The present study aimed to examine changes in selected psychophysiological characteristics in breast cancer patients from diagnosis through completion of adjuvant treatment. A longitudinal design with two assessment points was employed: before treatment initiation and after completion of adjuvant therapy. The sample consisted of 75 women with breast cancer (mean age = 52.04; sd = 11.63). Self-report measures assessed fatigue (MFI), quality of life (EORTC QLQ-C30), anxiety and depression (HADS), sleep quality (PSQI), and motivation for physical activity (MPAM-R). Objective indicators included body mass index (BMI) and functional exercise capacity measured by the six-minute walk test (6MWT). Changes over time were analyzed using General Linear Models for repeated measures, with age and treatment duration included as covariates. Holm-Bonferroni correction was applied to control for multiple testing. Following treatment, patients exhibited significant increases in physical and general fatigue and a marked deterioration in the physical component of quality of life. BMI increased modestly but significantly over time. In contrast, no significant change was observed in objectively measured physical fitness (6MWT). Depressive symptoms significantly decreased after treatment, suggesting psychological adaptation despite physical deterioration. Age-related effects indicated greater post-treatment worsening of sleep quality in younger women, whereas older women showed a more pronounced decline in physical quality of life. The findings reveal a notable discrepancy between subjective health perceptions and objective physical capacity during breast cancer treatment. They underscore the importance of routine monitoring of fatigue, quality of life, and body weight, and support the implementation of individualized, age-sensitive supportive care strategies. Addressing psychophysiological burden during treatment may improve long-term well-being and clinical outcomes in breast cancer survivors.